No definition available.
Sequelae of other and unspecified infectious and parasitic diseases
AB1_SEQULAE_INF_NOS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2456 |
4. Check minimum number of eventsNone |
2456 |
5. Include endpointsNone |
2456 |
6. Filter based on genotype QC (FinnGen only) |
2224 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Sequelae of other and unspecified infectious and parasitic diseases
based on the number of shared cases.
Similar with more cases:
- Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo
- Sequelae of infectious and parasitic diseases
- Sequelae of infectious and parasitic diseases, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 21962 | 9845 | 11952 |
| Only index persons | 18321 | 8154 | 10167 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.31 | 0.28 | 0.33 |
| Only index persons | 0.35 | 0.30 | 0.39 |
| Median age at first event (years) | |||
| Whole population | 14.15 | 14.25 | 13.58 |
| Only index persons | 10.07 | 10.00 | 10.12 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2224 | 1161 | 1063 |
| Unadjusted period prevalence (%) | 0.45 | 0.41 | 0.49 |
| Median age at first event (years) | 14.46 | 10.45 | 18.84 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2276
- Matched controls
- 22760
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
07999
ICD-8 Finland
Other viral diseases, Viral infection, unspecified
+∞
307.7
786
*
07997
ICD-8 Finland
Other viral diseases, Viroses suspectae
+∞
307.7
787
*
07988
ICD-8 Finland
Other viral diseases
+∞
243.2
229
*
07900
ICD-8 Finland
Other viral diseases, Molluscum contagiosum
+∞
151.8
144
*
07910
ICD-8 Finland
Other viral diseases, Viral warts
+∞
118.8
113
*
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
10.9
109.5
120
116
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
4.8
76.6
181
401
07981
ICD-8 Finland
Other viral diseases, Infectio virosa adeno alia
+∞
49.1
47
*
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
47.0
45
*
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
3.6
45.7
158
462
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
4.2
32.6
89
220
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
2.5
29.2
202
865
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
3.8
28.6
87
233
49300
ICD-8 Finland
Asthma, bronchiale
3.9
27.9
84
223
78880
ICD-8 Finland
Other general symptoms, Pyrexia of unknown origin
7.6
21.2
30
40
48609
ICD-8 Finland
Pneumonia, unspecified
3.7
20.0
64
178
79199
ICD-8 Finland
Headache
5.1
19.0
40
80
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
3.8
18.9
57
152
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.8
16.6
277
1637
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.8
14.8
72
259
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.2
14.3
118
546
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
2.7
14.2
75
282
A10AB01
ATC
insulin (human); parenteral
2.4
14.1
97
414
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
2.8
14.1
68
244
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
13.9
775
6031
R03AC02
ATC
salbutamol; inhalant
1.4
13.6
1190
10002
59010
ICD-8 Finland
Infections of kidney, Pyelonephritis
3.2
13.2
51
161
J01DA01
ATC
[U] cefalexin
1.4
12.5
1317
11338
07980
ICD-8 Finland
Other viral diseases, Infectio virosa ECHO
+∞
12.5
12
*
A10AA02, ,
ATC
2.4
12.4
87
375
03400
ICD-8 Finland
Streptococcal sore throat and scarlet fever, Streptococcal sore throat
5.0
12.4
26
52
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
12.4
388
2683
49099
ICD-8 Finland
Bronchitis, unspecified
3.7
12.4
38
103
48509
ICD-8 Finland
Bronchopneumonia, unspecified
3.2
12.4
49
157
A10AA01, ,
ATC
2.5
12.3
79
327
85000
ICD-8 Finland
Concussion, Current or unspecified
2.7
11.8
63
239
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
4.4
11.7
29
67
AA1AD
NOMESCO Finland
CT of head and brain
1.5
11.6
503
3711
R03AC12
ATC
salmeterol; inhalant
2.3
11.5
86
382
79388
ICD-8 Finland
Observation, without need for further medical care, Morbi alii definiti
5.0
11.5
24
48
07940
ICD-8 Finland
Other viral diseases, Foot and mouth disease
+∞
11.5
11
*
B94.80
ICD-10 Finland
Late effects of bacterial meningitis
120.6
11.4
12
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.6
11.1
65
258
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
28.2
10.7
14
5
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
4.7
10.5
24
52
78080
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Meningismus
110.5
10.4
11
*
A10AC01
ATC
insulin (human); parenteral
1.8
10.2
152
868
N02AX02
ATC
tramadol; systemic, rectal
1.3
10.1
867
7147
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
9.9
269
1798
A86
ICD-10 Finland
Unspecified viral encephalitis
8.1
9.8
21
26
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
9.6
371
2668
34609
ICD-8 Finland
Migraine, Unspecified
5.0
9.6
20
40
07959
ICD-8 Finland
Other viral diseases, Virosis cytomegalica NUD
+∞
9.4
9
*
B94.8
ICD-10 Finland
Sequelae of other specified infectious and parasitic diseases
+∞
9.4
9
*
J01AA02
ATC
doxycycline; systemic
1.4
9.4
1676
15294
H02AB04
ATC
methylprednisolone; systemic
1.5
9.4
279
1904
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
9.3
165
990
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
3.4
9.3
32
94
34599
ICD-8 Finland
Epilepsy, Other and unspecified
8.7
9.3
19
22
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.2
9.2
73
333
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
9.1
868
7234
J01FF01
ATC
clindamycin; systemic
1.4
9.0
539
4186
204
Kela drug reimbursment
Leukemia lymphatica
2.2
8.9
69
312
N03AG01
ATC
valproic acid; systemic, rectal
1.8
8.9
134
768
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
4.3
8.9
22
51
N06AB04
ATC
citalopram; systemic
1.4
8.7
417
3117
H3600, E103,
ICD-10 Finland
3.1
8.7
36
119
H3603, E103,
ICD-10 Finland
3.3
8.6
31
94
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
8.6
537
4196
78410
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Emesis
6.9
8.5
20
29
N03AX16
ATC
[U] pregabalin
1.4
8.5
439
3328
H02AB06
ATC
prednisolone; systemic
1.3
8.5
942
7999
B94.9
ICD-10 Finland
Sequelae of unspecified infectious or parasitic disease
90.4
8.4
9
*
1398X
ICD-9 Finland
Late effects of other infectious and parasitic diseases, Late effects of other and unspecified infectious and parasitic diseases
+∞
8.3
8
*
C03CA01
ATC
furosemide; systemic
1.4
8.3
412
3099
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
8.2
618
4964
J01FA06
ATC
roxithromycin; oral
1.3
8.2
797
6636
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.9
8.2
94
495
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
8.2
521
4082
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
4.0
8.1
22
55
N03AX18
ATC
lacosamide; systemic
3.7
8.0
25
69
R55
ICD-10 Finland
Syncope and collapse
1.6
8.0
174
1104
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.2
8.0
31
99
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
7.8
255
1774
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.4
7.7
49
204
Y0699
ICD-8 Finland
Examination of the urinary and genital organs, Urinary organs. Does not include urine tests to determine endocrine and metabolic disorders (Y 00.99)
3.4
7.7
26
76
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
7.6
385
2901
R03BA01
ATC
beclometasone; inhalant
1.5
7.6
261
1832
N05BA04
ATC
oxazepam; oral
1.3
7.6
502
3950
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
7.5
697
5750
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.3
7.5
27
82
N05AH04
ATC
quetiapine; oral
1.4
7.5
377
2839
SPAT1211
SPAT
Application of soft bandage
1.7
7.5
137
832
A10AB04
ATC
insulin lispro; parenteral
2.0
7.5
75
377
N05CD07
ATC
temazepam; oral
1.6
7.4
182
1189
Z94.0
ICD-10 Finland
Kidney transplant status
3.1
7.3
30
99
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
3.6
7.3
23
64
B94.89
ICD-10 Finland
Sequelae of other specified infectious and parasitic diseases
+∞
7.3
7
*
06608
ICD-8 Finland
Late effects of viral encephalitis, Alii casus postencephalitici
+∞
7.3
7
*
41399
ICD-8 Finland
Angina pectoris, Without mention of hypertensive disease
6.8
7.3
17
25
68409
ICD-8 Finland
Impetigo, Unspecified
15.8
7.2
11
7
L04AX01
ATC
azathioprine; systemic
1.9
7.2
87
467
N02AC04
ATC
dextropropoxyphene; oral
2.2
7.2
57
262
127
Kela drug reimbursment
Transplant complication
2.6
7.1
38
145
79399
ICD-8 Finland
Observation, without need for further medical care, Unspecified
3.2
7.1
27
85
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
7.1
467
3667
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.5
7.1
42
169
R06.0
ICD-10 Finland
Dyspnoea
1.3
7.1
475
3741
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
7.0
203
1375
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
7.0
7.0
16
23
H04AA01
ATC
glucagon; nasal, parenteral
2.3
7.0
51
226
J01DB01
ATC
cefalexin; oral
1.3
7.0
1774
16558
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
6.9
270
1942
A10AE04
ATC
insulin glargine; parenteral
1.6
6.8
173
1138
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
6.8
446
3496
S14
ICPC
Burn/scald
2.0
6.8
68
341
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
4.1
6.8
18
44
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.8
6.8
103
593
59000
ICD-8 Finland
Infections of kidney, Pyelonephritis chronica
6.7
6.8
16
24
N06AX16
ATC
venlafaxine; oral
1.4
6.8
303
2233
M79.6
ICD-10 Finland
Pain in limb
1.3
6.8
891
7663
7870A
ICD-9 Finland
Symptoms involving digestive system, Nausea and vomiting
6.1
6.8
17
28
SPD00
NOMESCO Finland
Mucosa borne complete denture
3.6
6.7
21
58
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
6.7
194
1315
63497
ICD-8 Finland
Other complications of pregnancy, Partus prematurus imminens, alibi non classificabilis
3.0
6.7
29
99
T89
ICPC
Diabetes insulin dependent
1.8
6.7
90
501
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
3.7
6.6
20
54
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
6.6
215
1493
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
6.5
507
4076
Y0899
ICD-8 Finland
Investigation of musculoskeletal system
5.3
6.5
18
34
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
7.4
6.4
14
19
L04AD02
ATC
tacrolimus; systemic
2.9
6.4
29
102
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.1
6.3
25
81
71490
ICD-8 Finland
Other specified forms of arthritis, Arthritis postinfectiosa NUD
9.3
6.3
12
13
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
3.9
6.3
18
47
07951
ICD-8 Finland
Other viral diseases, Virosis cytomegalica asquisita
+∞
6.3
6
*
07998, ,
ICD-8 Finland
+∞
6.3
6
*
58399
ICD-8 Finland
Nephritis, unqualified
26.7
6.2
8
*
J01MA02
ATC
ciprofloxacin; systemic
1.3
6.2
708
5972
C01DA14
ATC
isosorbide mononitrate; oral
1.5
6.2
182
1238
M05BA04
ATC
alendronic acid; oral
1.7
6.2
111
671
J02AC01
ATC
fluconazole; systemic
1.3
6.2
766
6526
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.2
187
1281
R02
ICPC
Shortness of breath/dyspnoea
1.5
6.1
217
1532
J01FA10
ATC
azithromycin; systemic
1.2
6.1
1177
10528
R42
ICD-10 Finland
Dizziness and giddiness
1.3
6.1
379
2945
S97
ICPC
Chronic ulcer skin
1.7
6.1
97
567
A10AE05
ATC
insulin detemir; parenteral
1.7
6.0
95
554
ZXD00
NOMESCO Finland
Emergency procedure
2.0
6.0
65
336
L04AA06
ATC
mycophenolic acid; systemic
2.3
6.0
44
196
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
465
3087
1.64
18.34
3.0
2.5
14.20
14.01
umol/l
0.20
436
2902
396
2616
1.62
15.70
3.2
2.6
23.95
23.82
%
0.06
371
2459
423
2863
1.59
15.11
3.1
2.5
2.35
2.37
g/l
0.32
390
2679
1235
10572
1.37
11.89
7.6
7.0
0.19
0.19
e9/l
0.08
1105
9418
409
2892
1.50
11.73
2.0
1.9
—
—
—
0
0
1069
8966
1.36
11.62
8.9
7.3
1.21
1.21
mmol/l
0.13
917
7835
956
7946
1.35
10.73
8.4
6.7
1.21
1.21
mmol/l
0.38
888
7440
1211
10432
1.34
10.69
7.4
6.8
1.92
1.94
e9/l
0.24
1091
9363
308
2119
1.52
9.96
1.9
1.8
—
—
—
0
0
673
5346
1.37
9.94
4.5
3.8
0.00
0.01
estimate
1.74
264
1860
709
5707
1.35
9.54
2.6
2.2
265.57
226.98
u/l
0.32
669
5466
35
108
3.28
9.45
1.2
1.1
—
—
—
0
0
1024
8715
1.32
9.33
2.8
2.5
76.42
75.24
nmol/l
0.70
952
8104
845
7009
1.33
9.20
4.1
3.3
32.23
51.82
ng/l
0.94
531
4365
960
8154
1.31
8.66
13.8
11.8
1.18
1.18
inr
0.09
817
6742
111
608
1.87
8.55
2.5
2.3
601.22
412.60
ug/l
0.35
106
573
599
4765
1.35
8.55
1.9
1.7
19.19
20.02
nmol/l
0.75
542
4179
261
1802
1.51
8.26
2.3
2.3
0.21
0.22
g/l
0.85
245
1703
289
2040
1.48
8.21
2.3
2.2
362.83
372.43
nmol/l
0.31
273
1906
1574
14357
1.31
7.98
5.0
4.3
11.18
10.36
mm/h
1.48
1496
13646
755
6272
1.30
7.82
3.5
3.4
2.35
2.35
mmol/l
0.02
683
5825
515
4065
1.34
7.62
3.4
2.6
4.48
5.65
e6/l
1.70
475
3711
411
3133
1.38
7.59
3.8
3.6
0.82
0.82
mmol/l
0.36
386
2991
251
1750
1.49
7.57
3.9
3.2
—
—
—
0
0
284
2031
1.46
7.53
1.9
1.8
—
—
—
0
0
1261
11232
1.28
7.39
10.3
10.2
4.16
4.05
e9/l
0.86
1110
9886
28
90
3.14
7.14
2.0
1.9
—
—
—
0
0
574
4650
1.31
7.02
2.7
2.3
2.82
2.76
mg/l
0.27
508
4059
913
7854
1.27
6.99
2.1
2.0
101.98
97.28
pmol/l
1.44
526
4381
366
2776
1.38
6.94
2.3
2.2
30.44
29.46
s
1.02
359
2692
188
1263
1.53
6.77
1.7
1.7
—
—
—
0
0
84
455
1.88
6.76
6.6
6.8
209.64
455.33
iu/ml
0.63
11
64
1598
14741
1.28
6.65
9.2
8.2
78.73
76.73
u/l
0.96
1539
14145
946
8219
1.26
6.53
5.8
5.2
35.92
36.44
g/l
2.23
873
7798
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
87
487
1.82
6.33
5.1
3.0
0.39
0.35
iu/ml
0.53
54
255
175
1181
1.52
6.19
3.8
3.2
5.23
5.17
kpa
0.39
168
1141
150
984
1.56
6.03
1.6
1.6
—
—
—
0
0
612
5092
1.28
5.96
4.2
3.1
0.30
0.39
e6/l
0.70
467
3683
1224
11021
1.24
5.91
6.3
5.1
6.89
6.65
mmol/l
2.00
1178
10483
1080
9597
1.24
5.88
3.6
3.1
121.81
119.78
ug/l
0.12
1032
9143
45
205
2.22
5.83
2.2
1.6
—
—
—
0
0
195
1363
1.47
5.82
4.3
3.9
1.22
1.23
mmol/l
0.54
172
1196
778
6676
1.25
5.80
4.3
3.3
—
1.14
—
0
6
311
2365
1.36
5.76
8.5
6.5
1.05
1.03
mmol/l
0.79
285
2219
1301
11817
1.24
5.70
5.0
4.1
9.80
1649.84
e6/l
2.29
15
168
149
990
1.54
5.68
3.6
3.1
1.48
1.56
mmol/l
0.08
107
738
224
1625
1.42
5.50
10.4
8.2
9.65
8.79
mmol/l
1.23
211
1565
273
2050
1.38
5.47
9.2
8.9
12.57
12.59
kpa
0.02
267
1982
273
2050
1.38
5.47
9.2
8.9
5.09
5.12
kpa
0.17
266
1981
1132
10162
1.23
5.43
4.2
3.6
3.87
0.17
estimate
0.47
260
1883
196
1394
1.44
5.36
2.7
2.9
75.46
72.51
e9/l
0.35
146
1039
717
6142
1.24
5.34
3.4
2.7
59.08
60.52
u/l
0.13
662
5770
1114
10018
1.22
5.15
4.2
3.6
0.00
0.00
estimate
0.80
268
1984
1108
9963
1.22
5.11
6.5
6.6
11.31
11.28
umol/l
0.02
1048
9563
269
2042
1.36
5.04
9.2
8.9
0.95
0.95
mmol/l
0.01
226
1680
346
2733
1.31
4.95
2.6
2.7
120.61
124.92
ug/g
0.10
268
2258
192
1390
1.42
4.78
1.4
1.3
40.48
49.70
au/ml
0.36
13
105
153
1066
1.47
4.69
11.8
11.4
24.55
24.38
mmol/l
0.25
147
1050
1119
10127
1.21
4.67
4.3
3.6
9.85
6.34
estimate
0.20
281
2021
690
5959
1.23
4.64
4.2
3.2
97.80
70.58
e6/l
0.18
545
4529
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
109
2.49
4.63
1.3
1.1
—
—
—
0
0
450
3718
1.26
4.51
1.8
1.7
21875437.56
42346103.07
pmol/l
0.39
384
3240
222
1666
1.37
4.48
10.5
8.6
1.29
1.35
mmol/l
0.26
217
1634
60
336
1.81
4.46
1.4
1.3
—
—
—
0
0
60
336
1.81
4.46
1.4
1.3
—
—
—
0
0
553
4688
1.24
4.40
2.0
1.7
0.88
0.97
mg/l
0.30
421
3578
84
520
1.64
4.38
1.7
1.8
—
—
—
0
0
1486
13860
1.21
4.35
3.3
3.2
—
—
—
0
0
328
2619
1.29
4.32
1.8
1.7
1177.45
1176.19
nmol/l
0.01
253
2050
201
1495
1.38
4.29
2.6
2.4
19.73
21.29
au/ml
0.11
27
195
10
16
6.27
4.29
1.4
1.1
—
—
—
0
0
175
1279
1.40
4.16
5.1
4.1
106.20
84.19
ng/l
1.10
145
1143
55
310
1.79
4.03
1.1
1.1
—
—
—
0
0
92
596
1.57
4.01
3.0
2.5
3.68
3.60
g/l
0.20
86
569
129
902
1.46
3.92
1.5
1.5
—
—
—
0
0
11
24
4.60
3.74
1.5
1.2
—
—
—
0
0
11
25
4.42
3.62
1.4
1.1
—
—
—
0
0
77
491
1.59
3.62
1.4
1.3
3.31
3.50
u/ml
—
7
35
547
4733
1.20
3.47
3.6
3.1
1103.98
1078.95
ng/l
0.05
459
3974
567
4925
1.20
3.45
5.0
4.1
91.54
92.84
%
0.64
554
4824
14
47
2.99
3.41
1.1
1.1
—
—
—
0
0
66
415
1.61
3.31
2.9
2.1
130.24
132.37
g/l
0.29
58
324
68
431
1.60
3.30
2.5
3.3
32.16
36.38
umol/l
0.78
62
397
14
48
2.93
3.30
1.2
1.1
—
—
—
0
0
1993
19306
1.26
3.28
18.6
14.3
22.00
22.61
mg/l
0.34
1697
15751
8
15
5.35
3.19
1.3
1.1
—
—
—
0
0
21
91
2.32
3.17
1.1
1.1
73.22
237.72
ng/l
—
9
22
92
630
1.48
3.17
3.7
3.4
24.14
24.82
mmol/l
1.47
85
589
40
222
1.82
3.15
1.1
1.0
—
—
—
0
0
124
901
1.40
3.11
1.8
2.0
3.66
7.16
iu/ml
1.82
30
239
401
3401
1.22
3.11
2.7
2.9
2.43
2.43
mmol/l
0.04
357
3063
60
375
1.62
3.10
5.3
3.2
10.91
9.04
pmol/l
0.41
60
375
96
667
1.46
3.08
1.6
1.8
0.22
0.24
g/l
0.79
91
634
129
946
1.39
3.07
1.5
2.2
41.53
40.04
u/l
0.34
121
864
99
697
1.44
2.98
1.6
1.8
1.14
1.19
g/l
0.90
94
662
546
4789
1.18
2.93
1.4
1.3
0.87
1.58
u/ml
2.43
152
1401
14
52
2.70
2.89
1.4
1.1
—
—
—
0
0
88
610
1.46
2.88
1.4
1.3
7.48
9.02
u/ml
0.11
11
98
120
880
1.38
2.88
1.3
1.3
0.63
1.06
u/ml
—
9
73
99
702
1.43
2.87
1.9
1.9
1.43
1.52
g/l
0.42
87
616
17
71
2.40
2.80
1.1
1.0
—
—
—
0
0
861
7854
1.15
2.79
4.2
3.4
2.07
0.03
estimate
0.49
244
1677
43
254
1.71
2.78
2.6
2.5
75.00
32.05
iu/ml
—
5
20
214
1715
1.27
2.78
6.0
3.7
1.57
1.92
mmol/l
0.72
189
1483
5
6
8.35
2.75
1.2
1.0
—
—
—
0
0
41
240
1.72
2.74
1.9
1.8
—
—
—
0
0
176
1378
1.30
2.74
2.5
2.8
66.25
67.40
g/l
1.23
164
1297
1938
18786
1.21
2.74
17.0
13.2
85.70
86.17
ml/min/173m2
0.50
1816
17389
7
14
5.01
2.73
1.0
1.5
—
—
—
0
0
14
54
2.60
2.70
1.4
1.1
—
—
—
0
0
18
79
2.29
2.67
1.4
1.1
—
—
—
0
0
1653
17194
0.86
2.64
21.9
17.7
333.14
333.34
g/l
0.36
1645
17100
86
605
1.44
2.63
1.4
1.3
4.84
2.83
u/ml
—
8
58
13
49
2.66
2.62
1.3
1.1
—
—
—
0
0
660
5929
1.16
2.60
5.2
4.1
7.99
8.17
mg/mmol
0.04
440
3831
712
6435
1.15
2.58
4.3
3.5
7.92
8.22
mmol/l
0.96
624
5596
176
1393
1.29
2.54
2.3
2.2
9.30
8.16
ug/l
0.21
151
1261
167
1313
1.29
2.54
3.7
3.7
4.46
4.57
pmol/l
0.79
158
1185
15
62
2.43
2.54
1.0
1.2
99.67
93.03
%
—
6
34
78
1101
0.70
2.54
1.1
1.1
0.56
0.66
ratio
2.37
12
117
27
143
1.90
2.51
1.1
1.2
—
1.73
—
0
5
91
655
1.41
2.47
1.4
1.3
120.98
16.27
u/ml
—
5
32
89
640
1.41
2.44
4.3
3.0
1.61
1.39
mg/l
1.35
83
598
84
599
1.42
2.41
1.5
2.3
11.82
11.09
mg/l
0.41
78
565
13
52
2.51
2.36
1.5
1.1
—
—
—
0
0
191
1545
1.26
2.33
1.4
1.3
498.42
224.23
u/ml
0.86
184
1444
21
105
2.01
2.31
1.8
1.8
—
—
—
0
0
25
134
1.88
2.26
1.2
1.1
1.06
1.06
ratio
0.07
25
112
234
1945
1.23
2.24
3.6
4.7
233.25
244.62
u/l
0.76
223
1857
56
375
1.51
2.24
1.4
1.6
—
—
—
0
0
228
1891
1.23
2.23
3.6
2.7
35.04
67.53
u/l
0.70
198
1629
11
41
2.69
2.20
1.0
1.3
131.18
108.80
%
1.51
11
41
59
401
1.48
2.20
1.8
1.5
165.29
152.33
au/ml
0.38
17
119
182
1480
1.25
2.14
5.3
3.1
5.08
4.65
kpa
1.63
177
1435
19
95
2.01
2.10
1.2
1.1
—
—
—
0
0
585
5282
1.14
2.10
2.6
2.5
336.75
339.32
umol/l
0.27
515
4778
247
2079
1.21
2.10
4.7
4.4
31.99
30.76
%
0.93
178
1484
64
447
1.44
2.09
1.4
1.5
—
—
—
0
0
14
62
2.27
2.07
1.0
1.5
108.50
94.57
%
—
6
35
775
7132
1.13
2.07
3.5
3.5
29.99
34.68
u/l
1.26
723
6771
15
69
2.18
2.04
2.3
2.6
—
—
—
0
0
363
3171
1.17
2.03
3.7
2.8
0.98
1.14
e6/l
0.32
199
1632
8
26
3.08
2.01
2.0
1.5
—
—
—
0
0
1580
15188
1.13
2.00
4.7
4.3
14.67
14.55
pmol/l
1.24
1490
14294
19
97
1.97
2.00
1.5
3.0
108.18
139.46
umol/l
0.28
11
54
30
178
1.69
1.99
4.9
4.0
—
—
—
0
0
33
201
1.65
1.99
1.5
1.6
0.88
1.30
promille
0.98
27
161
82
605
1.37
1.98
1.8
1.8
—
—
—
0
0
81
597
1.37
1.97
1.1
1.1
4.18
3.57
—
8
99
88
1164
0.75
1.97
1.1
1.1
1.47
1.51
g/l
0.92
88
1164
21
112
1.88
1.96
1.3
1.5
137.14
141.22
nmol/l
0.22
21
112
1990
19451
1.18
1.94
20.7
15.9
139.62
139.69
mmol/l
0.67
1953
19138
233
1967
1.21
1.94
6.3
6.1
—
—
—
0
0
33
203
1.63
1.92
1.5
1.9
—
—
—
0
0
33
203
1.63
1.92
2.6
2.1
22.72
19.96
mg/l
0.19
18
85
50
340
1.48
1.90
1.1
1.1
115.38
1814.44
iu/ml
0.49
13
73
8
28
2.86
1.86
1.3
1.1
—
—
—
0
0
33
205
1.62
1.86
2.4
2.0
0.83
0.78
mmol/l
0.03
28
200
43
285
1.52
1.85
1.2
1.2
—
11.43
—
0
12
201
1683
1.21
1.83
2.9
2.9
10.90
10.60
g/l
0.44
189
1569
34
214
1.60
1.82
1.1
1.1
—
—
—
0
0
14
66
2.13
1.82
2.4
3.1
0.62
0.61
mmol/l
0.04
14
66
66
478
1.39
1.81
1.7
1.4
671.16
1681.63
e6/l
0.73
49
377
67
487
1.39
1.80
1.2
1.3
—
—
—
0
0
1994
19517
1.17
1.78
20.9
16.0
3.97
3.97
mmol/l
0.12
1951
19166
58
413
1.41
1.76
2.2
2.5
50.55
139.34
ug/min
1.89
34
259
49
339
1.46
1.73
5.6
6.6
356.21
369.60
umol/l
0.31
44
296
90
690
1.32
1.73
1.3
1.3
—
—
—
0
0
69
508
1.37
1.73
1.6
1.4
—
—
—
0
0
136
1100
1.25
1.72
2.2
1.8
0.29
0.32
mg/l
0.24
72
563
8
30
2.67
1.72
1.8
3.9
38.50
38.57
umol/l
—
8
24
468
4217
1.14
1.72
1.5
1.5
2.48
2.41
g/l
0.25
298
2841
7
24
2.92
1.72
1.3
2.7
—
—
—
0
0
5
13
3.85
1.71
1.2
1.0
—
—
—
0
0
69
509
1.37
1.71
1.3
1.2
52.52
40.87
u/ml
—
6
54
177
1476
1.22
1.69
1.4
1.4
—
—
—
0
0
67
494
1.37
1.67
1.7
1.7
—
—
—
0
0
26
157
1.66
1.65
1.7
1.5
18.92
31.95
%
0.96
13
95
26
159
1.64
1.59
1.0
1.1
4.63
7.00
iu/ml
—
7
54
21
121
1.74
1.58
1.2
1.1
1913.53
1456.64
miu/ml
1.25
21
121
626
5771
1.12
1.57
3.6
3.0
1.08
0.07
estimate
0.46
234
1600
92
719
1.29
1.56
1.6
1.5
161.58
0.22
iu/ml
0.47
13
113
87
675
1.30
1.56
1.9
2.0
—
—
—
0
0
26
160
1.63
1.56
1.2
1.2
75.78
89.87
—
5
8
69
518
1.34
1.55
2.8
3.6
33.59
40.46
mg/l
0.51
55
439
69
518
1.34
1.55
2.8
3.6
43.68
56.71
mg/l
0.50
55
438
394
3537
1.14
1.54
4.1
3.6
350.28
445.47
ng/l
0.37
295
2494
27
169
1.60
1.52
1.4
1.2
—
42.67
—
0
6
7
27
2.60
1.51
1.7
1.1
—
—
—
0
0
119
966
1.24
1.50
5.1
2.9
1.32
1.31
%
0.02
119
960
26
162
1.61
1.49
4.4
2.5
—
—
—
0
0
63
470
1.35
1.49
1.7
1.4
30.38
23.29
e6/l
0.17
45
346
53
385
1.39
1.48
1.5
1.6
—
—
—
0
0
17
94
1.81
1.47
2.9
3.3
8.43
8.85
mg/l
0.12
11
77
74
569
1.31
1.44
1.6
1.4
304.59
288.65
ug/g
0.25
41
325
6
22
2.73
1.43
9.0
6.4
5.00
6.49
mmol/l
—
6
22
1537
14869
1.10
1.43
3.7
3.4
49.62
46.98
u/l
0.43
1469
14268
185
1578
1.19
1.43
2.7
2.6
70.52
73.51
ml/min/173m2
0.43
82
644
924
8731
1.10
1.41
3.0
2.6
—
—
estimate
—
0
0
48
346
1.40
1.41
1.6
1.6
—
—
—
0
0
60
449
1.35
1.41
1.4
1.2
325.62
270.60
u/ml
0.60
39
287
13
67
1.95
1.38
5.5
3.7
—
—
—
0
0
9
41
2.20
1.37
1.0
1.2
—
—
—
0
0
67
514
1.31
1.34
1.7
1.8
—
—
—
0
0
46
334
1.39
1.31
1.8
1.9
—
—
—
0
0
6
24
2.50
1.30
2.3
2.3
—
—
—
0
0
115
947
1.23
1.30
5.2
2.8
0.58
0.62
%
0.64
115
941
63
482
1.32
1.29
1.3
1.2
—
44.94
—
0
9
253
2234
1.15
1.28
2.8
2.4
13.48
13.96
nmol/l
0.46
235
2081
17
99
1.72
1.27
1.0
1.1
106.94
98.35
%
0.57
17
82
49
362
1.36
1.27
1.8
1.7
—
—
—
0
0
24
363
0.66
1.24
1.1
1.1
1.85
2.19
eliau/ml
0.17
11
182
6
25
2.40
1.24
2.3
2.2
—
—
—
0
0
268
2382
1.14
1.24
2.1
1.9
—
—
—
0
0
32
220
1.46
1.23
1.4
1.6
282.00
281.40
mosm/kgh2o
0.04
25
166
1705
16629
1.10
1.22
21.4
17.3
13.58
13.49
%
2.45
1685
16430
42
305
1.38
1.21
1.4
1.5
—
—
—
0
0
322
2905
1.13
1.19
3.8
2.9
2.47
2.47
e6/l
0.00
156
1364
52
393
1.33
1.18
1.1
1.1
12.35
3.61
u/ml
0.82
23
160
349
3166
1.12
1.17
1.6
1.5
—
—
—
0
0
11
57
1.93
1.17
1.0
1.8
42.51
41.73
g/l
0.16
11
57
28
190
1.48
1.16
1.5
2.0
—
—
—
0
0
445
4095
1.11
1.16
1.4
1.3
30.44
26.03
iu/ml
0.43
136
1243
5
20
2.50
1.15
3.4
2.5
0.20
0.90
u/field
—
5
20
22
142
1.55
1.14
1.9
2.1
—
—
—
0
0
70
555
1.27
1.13
2.7
3.0
—
—
—
0
0
128
1087
1.19
1.09
1.0
1.1
—
—
—
0
0
12
66
1.82
1.09
1.2
1.7
—
—
—
0
0
45
592
0.76
1.08
1.1
1.1
0.68
3.19
eliau/ml
—
6
88
108
905
1.20
1.07
1.6
1.8
4.13
4.73
mg/l
0.13
82
676
7
33
2.12
1.05
2.4
2.0
9.14
1023085.15
nmol/l
—
7
26
19
122
1.56
1.02
1.3
1.2
—
—
—
0
0
1823
17884
1.10
1.02
5.6
5.2
1.87
1.83
mu/l
0.19
1726
16912
34
248
1.38
0.99
1.4
1.2
—
—
—
0
0
29
206
1.41
0.98
1.7
1.7
56.57
55.32
%
0.05
14
134
38
283
1.35
0.98
3.6
3.2
157.71
101.14
u/ml
0.14
38
277
345
3163
1.11
0.98
1.9
1.9
1.49
1.45
%
0.41
300
2843
66
531
1.25
0.98
1.5
1.4
—
—
—
0
0
15
92
1.63
0.97
1.5
1.7
85.09
109.44
ng/l
1.13
15
92
98
824
1.20
0.96
1.6
1.7
14.92
12.83
u/ml
0.17
18
224
43
328
1.32
0.96
1.1
1.1
2.92
2.35
—
5
63
660
6241
1.08
0.94
4.5
4.3
1.63
1.99
ug/l
1.66
610
5757
13
78
1.67
0.91
1.2
1.8
—
—
—
0
0
13
78
1.67
0.91
1.2
1.8
—
—
—
0
0
16
102
1.57
0.90
1.8
1.4
85.43
70.33
%
—
7
12
57
457
1.25
0.89
6.9
2.3
1.17
0.93
nmol/l
0.64
48
403
68
557
1.23
0.88
2.6
2.3
0.31
0.74
g/l
1.18
62
496
22
152
1.45
0.88
1.3
1.3
5636.47
2073.04
e6/l
0.48
17
98
18
120
1.50
0.85
1.7
1.5
—
—
—
0
0
8
45
1.78
0.84
1.5
1.1
82.75
95.38
%
—
8
45
27
196
1.38
0.84
1.2
1.2
—
—
—
0
0
19
129
1.48
0.83
2.1
2.4
929.00
653.64
ml
1.04
14
85
256
2336
1.11
0.82
2.8
2.9
7.72
7.39
umol/l
0.13
223
2063
402
3748
1.09
0.82
1.4
1.3
10.01
10.26
u/ml
0.02
158
1584
15
97
1.55
0.81
1.5
1.4
—
481.67
—
0
6
24
172
1.40
0.81
1.0
1.0
—
—
—
0
0
1873
18450
1.09
0.79
6.7
5.7
39.46
38.69
mmol/mol
3.06
1783
17653
117
1019
1.16
0.79
1.4
1.4
—
—
—
0
0
147
1303
1.14
0.78
1.8
1.9
1.28
1.35
g/l
0.21
135
1221
2093
20729
1.12
0.77
22.4
17.6
76.94
75.87
umol/l
0.81
2082
20552
17
115
1.48
0.76
1.8
1.5
—
—
—
0
0
82
696
1.18
0.76
2.2
2.1
2.57
1.91
ug/l
0.30
75
634
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
93
799
1.17
0.75
2.3
2.0
212.42
212.19
pmol/l
0.01
93
760
480
4525
1.08
0.75
2.7
2.3
—
—
—
0
0
26
192
1.36
0.75
1.2
1.1
40.44
41.51
mg/l
0.04
21
154
5
24
2.09
0.74
1.2
1.0
—
—
—
0
0
22
158
1.40
0.74
1.5
1.9
—
—
—
0
0
59
487
1.22
0.74
2.7
3.0
1.47
1.83
index
0.25
30
268
19
133
1.43
0.73
1.1
1.2
—
—
—
0
0
46
370
1.25
0.73
1.2
1.2
4.26
3.99
u/ml
0.08
19
167
22
159
1.39
0.72
1.2
1.1
—
—
—
0
0
21
151
1.39
0.71
1.3
1.3
—
—
—
0
0
21
151
1.39
0.71
1.3
1.3
—
—
—
0
0
9
57
1.58
0.71
2.6
1.9
85.56
52.29
ug/l
—
9
57
25
332
0.75
0.71
6.8
2.9
7.81
7.26
mmol/l
0.37
25
323
15
101
1.49
0.70
1.3
1.1
—
—
—
0
0
9
143
0.63
0.69
1.2
1.5
85.00
77.17
umol/l
—
9
143
48
391
1.23
0.69
1.1
1.1
6.64
16.33
au/ml
1.98
11
121
408
3837
1.08
0.69
2.9
2.8
0.68
0.71
ug/l
0.25
238
2108
32
248
1.29
0.69
2.0
1.6
—
—
—
0
0
11
69
1.60
0.68
1.1
1.2
—
—
—
0
0
45
365
1.24
0.68
1.1
1.0
0.19
0.20
u/ml
0.04
17
108
18
128
1.41
0.65
1.8
1.5
—
—
—
0
0
34
427
0.79
0.65
1.5
1.4
55.90
59.21
ug/l
0.17
28
319
46
377
1.22
0.64
1.1
1.1
—
—
—
0
0
88
766
1.15
0.63
1.2
1.4
12.49
9.04
u/l
1.13
74
618
50
414
1.21
0.63
1.1
1.1
3.58
2.38
u/ml
0.32
22
195
12
79
1.52
0.62
1.7
1.6
—
—
—
0
0
15
104
1.45
0.62
1.1
1.1
—
49.20
—
0
10
64
544
1.18
0.62
1.2
1.1
—
—
—
0
0
63
535
1.18
0.62
1.2
1.1
0.73
1.94
u/ml
1.69
32
268
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
68
791
0.86
0.61
1.5
1.5
—
—
—
0
0
64
546
1.18
0.60
1.2
1.1
—
—
—
0
0
30
378
0.79
0.60
4.3
3.6
20.24
25.18
mg/l
0.49
14
255
14
97
1.45
0.59
2.1
2.2
146.71
141.11
nmol/l
0.10
14
85
22
166
1.33
0.58
1.2
1.1
—
—
—
0
0
22
166
1.33
0.58
1.2
1.1
—
—
—
0
0
21
158
1.33
0.57
1.2
1.2
—
—
—
0
0
55
466
1.18
0.57
3.0
3.4
1.39
2.20
ratio
1.90
25
268
57
485
1.18
0.56
2.9
2.1
0.01
0.00
g/l
0.49
50
428
19
252
0.75
0.56
1.6
1.5
—
—
—
0
0
8
55
1.46
0.56
1.8
2.2
15.55
15.85
umol/l
—
8
55
55
467
1.18
0.56
1.3
1.2
—
—
—
0
0
170
1559
1.10
0.54
1.3
1.4
23.52
26.23
iu/l
0.60
148
1335
58
496
1.17
0.54
2.8
2.1
0.02
0.01
g/l
0.13
52
454
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
6
38
1.58
0.54
1.2
1.2
—
—
—
0
0
56
478
1.18
0.54
1.7
1.6
8505.48
11414.22
e6/l
0.48
42
335
30
240
1.25
0.54
1.1
1.3
—
—
—
0
0
17
125
1.36
0.53
2.1
2.1
4.44
2.22
u/field
—
9
68
66
574
1.15
0.51
2.0
2.1
6.34
4.13
iu/l
0.44
24
257
16
214
0.75
0.51
1.1
1.0
—
—
—
0
0
24
188
1.28
0.51
1.9
1.9
19.56
20.66
ug/l
0.07
24
183
70
797
0.87
0.50
2.5
2.2
4838.67
5168.82
u/l
0.02
22
282
85
758
1.13
0.47
1.5
1.8
—
—
—
0
0
280
2641
1.07
0.47
2.2
2.0
—
—
—
0
0
22
173
1.27
0.46
1.2
1.1
—
—
—
0
0
34
407
0.83
0.46
1.4
1.3
1.08
1.18
ratio
0.31
23
228
34
407
0.83
0.46
1.4
1.3
—
—
—
0
0
34
407
0.83
0.46
1.4
1.4
1.00
0.96
ratio
0.24
23
228
34
407
0.83
0.46
1.4
1.4
1.17
1.17
ratio
0.00
23
228
873
8505
1.04
0.44
1.9
1.9
1.47
1.45
mmol/l
0.29
735
7441
20
157
1.28
0.43
1.1
1.3
5.99
6.34
mmol/l
0.21
15
147
5
31
1.61
0.43
2.2
1.9
—
—
—
0
0
46
396
1.16
0.43
1.5
1.4
—
—
—
0
0
127
1167
1.09
0.42
2.8
2.9
134.31
166.94
ng/l
0.57
110
1044
8
57
1.40
0.42
1.0
1.0
24.32
43.80
iu/ml
—
8
57
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
27
222
1.22
0.41
1.4
1.4
171.87
201.82
pmol/l
0.29
27
222
121
1114
1.09
0.39
5.7
3.2
126.29
132.52
g/l
2.31
121
1090
43
496
0.86
0.39
1.7
1.4
—
—
—
0
0
2078
20658
1.07
0.38
13.2
11.4
27.50
28.26
u/l
1.29
2033
20268
34
289
1.18
0.38
1.5
1.3
—
—
—
0
0
42
364
1.16
0.37
2.2
1.3
24.10
23.62
u/l
0.02
36
311
10
72
1.39
0.37
1.4
1.5
9.77
8.27
ug/l
—
10
72
25
207
1.21
0.36
1.8
1.6
—
—
—
0
0
25
207
1.21
0.36
1.8
1.6
—
—
—
0
0
25
208
1.20
0.35
1.8
1.6
—
—
—
0
0
46
404
1.14
0.35
1.3
1.7
—
—
—
0
0
29
341
0.85
0.35
1.3
1.4
—
—
—
0
0
14
109
1.29
0.33
2.4
2.5
16.69
93.27
ug/l
0.54
14
97
63
698
0.90
0.33
1.5
1.4
1052.22
1104.49
mu/l
0.17
48
511
179
1689
1.06
0.33
4.1
4.5
102.79
21.40
ug/l
0.43
147
1352
26
219
1.19
0.33
1.2
1.4
—
—
—
0
0
22
183
1.20
0.31
1.8
1.7
—
—
—
0
0
23
194
1.19
0.29
1.1
1.2
1.93
0.72
u/ml
0.33
14
103
42
373
1.13
0.29
1.3
1.2
7.00
3.63
u/ml
0.26
16
128
25
213
1.18
0.29
1.8
1.6
—
—
—
0
0
464
4507
1.04
0.28
4.5
3.7
1.02
1.35
kg/l
0.50
335
2996
292
3033
0.96
0.28
2.0
2.0
3.69
3.63
ratio
0.29
224
2354
17
140
1.22
0.27
1.6
3.6
—
—
—
0
0
8
64
1.25
0.27
1.0
1.4
—
—
—
0
0
17
141
1.21
0.26
1.0
1.1
1.11
1.12
u/l
—
7
69
51
463
1.10
0.25
1.2
1.1
0.98
1.46
u/ml
0.44
22
216
511
4987
1.03
0.24
3.8
3.6
22.04
21.13
%
0.47
202
1986
25
217
1.15
0.24
1.8
1.6
—
—
—
0
0
25
217
1.15
0.24
1.2
1.3
—
—
—
0
0
25
217
1.15
0.24
1.8
1.6
—
—
—
0
0
150
1429
1.05
0.23
2.2
2.0
—
—
—
0
0
434
4230
1.03
0.23
1.6
1.5
—
—
—
0
0
92
864
1.07
0.22
6.4
3.8
49.19
49.49
%
0.03
92
850
24
274
0.87
0.22
2.0
1.7
—
—
—
0
0
219
2274
0.96
0.22
1.7
1.7
3.52
3.54
mmol/l
0.06
156
1581
5
40
1.25
0.22
3.6
2.1
—
—
—
0
0
15
125
1.20
0.22
1.7
1.5
1.88
1.32
nmol/l
—
10
97
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
17
144
1.18
0.22
2.2
1.6
—
—
—
0
0
13
107
1.22
0.21
1.2
1.4
106.85
178.14
mmol/24h
3.11
13
107
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
84.64
—
0
11
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
4085.60
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
20.36
—
0
5
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
5
43
1.16
0.21
10.4
6.9
6.58
5.22
kpa
—
5
43
22
192
1.15
0.20
1.0
1.1
19.81
17.33
u/ml
—
7
83
19
219
0.87
0.20
1.4
1.4
59.93
59.00
ug/l
0.03
19
219
0
14
0.00
0.20
0.0
6.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
49
1.23
0.20
1.2
1.4
—
0.82
—
0
5
9
113
0.80
0.20
1.4
1.4
8.22
7.96
mmol/l
—
9
108
22
193
1.14
0.19
17.6
21.3
1426.27
1443.98
nmol/l
0.04
22
188
38
346
1.10
0.19
2.4
4.0
20305.23
928.98
u/ml
0.58
33
326
15
128
1.17
0.18
1.3
1.8
—
—
—
0
0
7
61
1.15
0.17
1.7
1.2
—
—
—
0
0
26
287
0.90
0.16
1.0
1.1
—
—
—
0
0
6
79
0.76
0.15
3.3
3.4
1.17
1.26
%
—
6
79
9
81
1.11
0.15
1.6
1.2
—
—
—
0
0
60
566
1.06
0.15
2.8
2.1
9.79
10.48
g/l
0.72
55
522
8
96
0.83
0.13
1.3
2.2
—
—
—
0
0
8
96
0.83
0.13
1.3
2.2
—
—
—
0
0
8
96
0.83
0.13
1.3
2.2
—
—
—
0
0
8
96
0.83
0.13
1.3
2.2
—
—
—
0
0
12
103
1.17
0.13
1.6
3.6
0.92
0.83
index
0.13
12
103
15
170
0.88
0.13
1.1
1.8
—
—
—
0
0
15
170
0.88
0.13
1.1
1.8
—
—
—
0
0
15
170
0.88
0.13
1.1
1.8
—
—
—
0
0
17
151
1.13
0.13
1.3
1.2
0.54
0.60
ratio
—
8
84
32
296
1.08
0.13
1.8
1.6
300.92
342.22
mu/l
0.55
24
237
31
287
1.08
0.12
1.1
1.4
0.61
6.68
nmol/l
0.49
31
279
120
1161
1.04
0.12
2.1
1.9
—
—
—
0
0
2140
21358
1.03
0.12
27.3
21.6
6.78
6.66
e9/l
1.44
2108
21000
2139
21348
1.03
0.12
27.1
21.5
90.94
90.72
fl
1.56
2127
21193
10
116
0.86
0.12
1.1
1.3
—
—
—
0
0
11
95
1.16
0.11
1.5
1.4
—
—
—
0
0
12
136
0.88
0.11
1.1
1.1
—
—
—
0
0
18
163
1.11
0.10
1.4
1.1
100.61
110.72
pmol/l
0.61
18
163
2139
21352
1.03
0.10
27.2
21.5
4.55
4.59
e12/l
3.15
2104
20999
97
938
1.04
0.10
1.3
1.6
266.54
288.16
mu/l
0.37
87
868
2139
21353
1.03
0.10
27.9
22.0
41.07
41.59
%
0.99
2126
21187
11
96
1.15
0.10
1.3
1.4
—
—
—
0
0
11
96
1.15
0.10
1.3
1.4
—
—
—
0
0
68
708
0.96
0.10
1.6
1.5
—
—
—
0
0
14
125
1.12
0.10
1.1
1.2
—
—
—
0
0
5
44
1.14
0.10
2.8
3.0
—
—
—
0
0
29
271
1.07
0.09
1.3
1.4
309.68
366.84
pmol/l
0.53
22
236
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
2139
21356
1.03
0.09
27.4
21.7
137.22
138.25
g/l
2.59
2127
21200
6
58
1.03
0.08
1.2
1.2
—
—
—
0
0
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
7
64
1.09
0.08
7.7
2.9
10.17
10.36
kpa
—
7
64
7
64
1.09
0.08
7.7
2.9
4.52
4.76
kpa
—
7
64
2137
21340
1.02
0.08
27.2
21.6
255.88
254.30
e9/l
0.55
2109
21036
1874
18783
0.99
0.07
4.4
4.1
1.37
1.35
mmol/l
0.49
1762
17779
42
402
1.05
0.07
1.4
1.4
26.28
25.63
u/l
0.05
34
328
14
128
1.09
0.06
2.4
9.4
—
52.70
u/ml
—
0
40
45
433
1.04
0.06
1.3
1.4
0.28
0.44
nmol/l
1.92
33
335
22
207
1.06
0.06
1.0
1.1
294.18
279.37
mg/l
0.44
22
191
1852
18556
0.99
0.06
5.0
4.7
5.96
5.88
mmol/l
1.37
1747
17498
21
198
1.06
0.05
7.6
5.2
326.36
93.41
u/ml
—
7
60
66
644
1.03
0.05
3.3
3.9
55.96
2268.54
u/ml
0.84
59
564
78
765
1.02
0.04
1.5
1.4
—
—
—
0
0
151
1527
0.99
0.03
2.6
2.4
0.41
0.41
e6/l
0.00
143
1447
26
250
1.04
0.03
4.4
3.2
1.05
0.84
nmol/l
0.32
17
202
1964
19660
0.99
0.03
5.1
4.8
1.42
1.43
mmol/l
0.39
1863
18716
42
409
1.03
0.03
5.4
2.9
1.53
1.57
mmol/l
0.10
42
396
1971
19725
0.99
0.02
5.1
4.9
4.69
4.74
mmol/l
1.53
1874
18865
1989
19903
0.99
0.02
5.7
5.4
2.79
2.83
mmol/l
1.38
1881
18964
36
352
1.02
0.01
1.9
2.1
4.08
5.36
mmol/24h
2.04
31
316
74
749
0.99
0.01
1.2
1.3
226.97
198.58
miu/ml
0.31
31
352
48
472
1.02
0.01
1.1
1.1
0.63
1.17
u/ml
0.61
19
189
19
184
1.03
0.00
1.6
2.1
10.64
7.11
umol/l
0.38
12
131
16
159
1.01
0.00
2.1
3.0
1344.31
1281.46
mg
0.04
16
159
50
495
1.01
0.00
1.1
1.1
3.25
4.42
u/ml
0.35
22
254
16
164
0.98
0.00
1.1
1.6
—
—
—
0
0
152
1519
1.00
0.00
1.2
1.2
131.80
141.45
u/ml
0.12
58
592
13
132
0.98
0.00
1.0
1.2
7.92
8.51
mm/h
0.10
13
132
11
113
0.97
0.00
1.8
1.8
2.03
4.07
nmol/l
—
6
86
10
97
1.03
0.00
1.1
1.1
234.54
190.73
iu/ml
—
10
97
7
70
1.00
0.00
1.3
1.4
—
—
—
0
0
7
73
0.96
0.00
1.3
2.5
—
—
—
0
0
8
86
0.93
0.00
1.0
1.1
—
—
—
0
0
7
73
0.96
0.00
1.3
2.5
—
—
—
0
0
7
70
1.00
0.00
1.3
1.4
—
—
—
0
0
7
73
0.96
0.00
1.3
2.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
1294.43
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
338.67
—
0
6
7
75
0.93
-0.00
1.0
1.1
76.06
51.19
u/ml
—
7
75
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
10.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.01
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint AB1_SEQULAE_INF_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_SEQULAE_INF_NOS | 2.439 [1.53, 3.88] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.581 |
During the follow-up period (1.1.1998 — 31.12.2019), 68 out of 237 females with AB1_SEQULAE_INF_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_SEQULAE_INF_NOS | 2.677 [1.74, 4.12] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.062 |
During the follow-up period (1.1.1998 — 31.12.2019), 101 out of 274 males with AB1_SEQULAE_INF_NOS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_SEQULAE_INF_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.249% | 0.647% |
| 5 | 1.448% | 3.526% |
| 10 | 3.887% | 8.412% |
| 15 | 7.002% | 15.39% |
| 20 | 12.447% | 24.513% |
Relationships between endpoints
↥Index endpoint: AB1_SEQULAE_INF_NOS – Sequelae of other and unspecified infectious and parasitic diseases
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data